Cullinan Therapeutics, Inc.(CGEM)
Biopharmaceutical company focused on oncology and autoimmune diseases
1 Insight
Investment Insights
AI-generated insights about Cullinan Therapeutics, Inc. from various financial sources
Monday, April 6, 2026
Very Bullish
Target: $19
Trading at a discount ($15) relative to a recent private placement price ($19) paid by smart money investors.
Monday, April 6, 2026
Very Bullish
Target: $19
Trading at a discount ($15) relative to a recent private placement price ($19) paid by smart money investors.